CARDIFF ONCOLOGY, INC. Comprehensive Income
CARDIFF ONCOLOGY, INC. (CRDF) reported Comprehensive Income of -$9.24 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Income Statement › Unrealized Gains
us-gaap:ComprehensiveIncomeNetOfTax · last filed 2026-08-11
- CARDIFF ONCOLOGY, INC. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2026-06-30 was -$9.24M.
- CARDIFF ONCOLOGY, INC. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2026-03-31 was -$12.44M.
- CARDIFF ONCOLOGY, INC. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2025-12-31 was -$7.22M.
- CARDIFF ONCOLOGY, INC. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2025-09-30 was -$11.22M.
- CARDIFF ONCOLOGY, INC. comprehensive income (loss), net of tax, attributable to parent for fiscal 2025 was -$45.84M.
- CARDIFF ONCOLOGY, INC. comprehensive income (loss), net of tax, attributable to parent for fiscal 2024 was -$45.33M.
- CARDIFF ONCOLOGY, INC. comprehensive income (loss), net of tax, attributable to parent for fiscal 2023 was -$41.11M.
- CARDIFF ONCOLOGY, INC. comprehensive income (loss), net of tax, attributable to parent for fiscal 2022 was -$38.96M.
| Period end | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 3 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 3 month as first filed | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 6 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 6 month as first filed | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 9 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | -$9.24M 10-Q · filed 2026-08-11 | -$21.69M 10-Q · filed 2026-08-11 | -$28.91M derived: sum of 3 quarters · filed 2026-08-11 | -$40.13M derived: sum of 4 quarters · filed 2026-08-11 | ||
| 2026-03-31 | -$12.44M 10-Q · filed 2026-05-14 | -$19.66M derived: sum of 2 quarters · filed 2026-05-14 | -$30.89M derived: sum of 3 quarters · filed 2026-05-14 | -$44.84M derived: sum of 4 quarters · filed 2026-08-11 | ||
| 2025-12-31 | -$7.22M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | -$18.44M derived: sum of 2 quarters · filed 2026-02-24 | -$32.39M derived: sum of 3 quarters · filed 2026-08-11 | -$45.84M 10-K · filed 2026-02-24 | ||
| 2025-09-30 | -$11.22M 10-Q · filed 2025-11-06 | -$25.18M derived: sum of 2 quarters · filed 2026-08-11 | -$38.62M 10-Q · filed 2025-11-06 | -$50.45M derived: sum of 4 quarters · filed 2026-08-11 | ||
| 2025-06-30 | -$13.95M 10-Q · filed 2026-08-11 | -$27.39M 10-Q · filed 2026-08-11 | -$39.23M derived: sum of 3 quarters · filed 2026-08-11 | -$50.91M derived: sum of 4 quarters · filed 2026-08-11 | ||
| 2025-03-31 | -$13.44M 10-Q · filed 2026-05-14 | -$25.28M derived: sum of 2 quarters · filed 2026-05-14 | -$36.95M derived: sum of 3 quarters · filed 2026-05-14 | -$48.70M derived: sum of 4 quarters · filed 2026-05-14 | ||
| 2024-12-31 | -$11.84M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | -$23.51M derived: sum of 2 quarters · filed 2026-02-24 | -$35.25M derived: sum of 3 quarters · filed 2026-02-24 | -$45.33M 10-K · filed 2026-02-24 | ||
| 2024-09-30 | -$11.68M 10-Q · filed 2025-11-06 | -$23.42M derived: sum of 2 quarters · filed 2025-11-06 | -$33.49M 10-Q · filed 2025-11-06 | -$42.49M derived: sum of 4 quarters · filed 2025-11-06 | ||
| 2024-06-30 | -$11.74M 10-Q · filed 2025-07-29 | -$21.82M 10-Q · filed 2025-07-29 | -$30.82M derived: sum of 3 quarters · filed 2025-07-29 | -$40.52M derived: sum of 4 quarters · filed 2025-07-29 | ||
| 2024-03-31 | -$10.08M 10-Q · filed 2025-05-08 | -$19.07M derived: sum of 2 quarters · filed 2025-05-08 | -$28.78M derived: sum of 3 quarters · filed 2025-05-08 | -$40.28M derived: sum of 4 quarters · filed 2025-05-08 | ||
| 2023-12-31 | -$9.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | -$18.70M derived: sum of 2 quarters · filed 2025-02-27 | -$30.21M derived: sum of 3 quarters · filed 2025-02-27 | -$41.11M 10-K · filed 2025-02-27 | ||
| 2023-09-30 | -$9.71M 10-Q · filed 2024-11-07 | -$21.21M derived: sum of 2 quarters · filed 2024-11-07 | -$32.12M 10-Q · filed 2024-11-07 | -$40.43M derived: sum of 4 quarters · filed 2024-11-07 | ||
| 2023-06-30 | -$11.51M 10-Q · filed 2024-08-08 | -$22.41M 10-Q · filed 2024-08-08 | -$30.72M derived: sum of 3 quarters · filed 2024-08-08 | -$39.09M derived: sum of 4 quarters · filed 2024-08-08 | ||
| 2023-03-31 | -$10.90M 10-Q · filed 2024-05-02 | -$19.22M derived: sum of 2 quarters · filed 2024-05-02 | -$27.59M derived: sum of 3 quarters · filed 2024-05-02 | -$38.26M derived: sum of 4 quarters · filed 2024-05-02 | ||
| 2022-12-31 | -$8.31M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | -$16.68M derived: sum of 2 quarters · filed 2024-02-29 | -$27.36M derived: sum of 3 quarters · filed 2024-02-29 | -$38.96M 10-K · filed 2024-02-29 | ||
| 2022-09-30 | -$8.37M 10-Q · filed 2023-11-02 | -$19.05M derived: sum of 2 quarters · filed 2023-11-02 | -$30.64M 10-Q · filed 2023-11-02 | -$40.24M derived: sum of 4 quarters · filed 2023-11-02 | ||
| 2022-06-30 | -$10.68M 10-Q · filed 2023-08-09 | -$22.28M 10-Q · filed 2023-08-09 | -$31.88M derived: sum of 3 quarters · filed 2023-08-09 | -$38.76M derived: sum of 4 quarters · filed 2023-08-09 | ||
| 2022-03-31 | -$11.60M 10-Q · filed 2023-05-04 | -$21.20M derived: sum of 2 quarters · filed 2023-05-04 | -$28.09M derived: sum of 3 quarters · filed 2023-05-04 | -$34.79M derived: sum of 4 quarters · filed 2023-05-04 | ||
| 2021-12-31 | -$9.60M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-02 | -$16.49M derived: sum of 2 quarters · filed 2023-03-02 | -$23.19M derived: sum of 3 quarters · filed 2023-03-02 | -$28.43M 10-K · filed 2023-03-02 | ||
| 2021-09-30 | -$6.89M 10-Q · filed 2022-11-03 | -$13.59M derived: sum of 2 quarters · filed 2022-11-03 | -$18.83M 10-Q · filed 2022-11-03 | -$25.43M derived: sum of 4 quarters · filed 2022-11-03 | ||
| 2021-06-30 | -$6.70M 10-Q · filed 2022-08-04 | -$11.95M 10-Q · filed 2022-08-04 | -$18.54M derived: sum of 3 quarters · filed 2022-08-04 | -$23.04M derived: sum of 4 quarters · filed 2022-08-04 | ||
| 2021-03-31 | -$5.25M 10-Q · filed 2022-05-05 | -$11.84M derived: sum of 2 quarters · filed 2022-05-05 | -$16.34M derived: sum of 3 quarters · filed 2022-05-05 | -$20.46M derived: sum of 4 quarters · filed 2022-05-05 | ||
| 2020-12-31 | -$6.60M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | -$11.09M derived: sum of 2 quarters · filed 2022-02-24 | -$15.22M derived: sum of 3 quarters · filed 2022-02-24 | -$19.31M 10-K · filed 2022-02-24 | ||
| 2020-09-30 | -$4.50M 10-Q · filed 2021-11-04 | -$8.62M derived: sum of 2 quarters · filed 2021-11-04 | -$12.71M 10-Q · filed 2021-11-04 | |||
| 2020-06-30 | -$4.12M 10-Q · filed 2021-08-05 | -$8.21M 10-Q · filed 2021-08-05 | ||||
| 2020-03-31 | -$4.09M 10-Q · filed 2021-05-06 | |||||
| 2018-12-31 | -$6.95M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-06 | -$10.72M derived: sum of 2 quarters · filed 2019-03-06 | -$14.47M derived: sum of 3 quarters · filed 2019-03-06 | -$19.25M 10-K · filed 2019-03-06 | ||
| 2018-09-30 | -$3.77M 10-Q · filed 2018-11-07 | -$7.52M derived: sum of 2 quarters · filed 2018-11-07 | -$12.30M 10-Q · filed 2018-11-07 | -$14.88M derived: sum of 4 quarters · filed 2019-03-06 | ||
| 2018-06-30 | -$3.75M 10-Q · filed 2018-08-03 | -$8.53M 10-Q · filed 2018-08-03 | -$11.11M derived: sum of 3 quarters · filed 2019-03-06 | -$15.41M derived: sum of 4 quarters · filed 2019-03-06 | ||
| 2018-03-31 | -$4.79M 10-Q · filed 2018-05-08 | -$7.36M derived: sum of 2 quarters · filed 2019-03-06 | -$11.66M derived: sum of 3 quarters · filed 2019-03-06 | -$19.70M derived: sum of 4 quarters · filed 2019-03-06 | ||
| 2017-12-31 | -$2.58M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-06 | -$6.87M derived: sum of 2 quarters · filed 2019-03-06 | -$14.92M derived: sum of 3 quarters · filed 2019-03-06 | -$24.92M 10-K · filed 2019-03-06 | ||
| 2017-09-30 | -$4.29M 10-Q · filed 2018-11-07 | -$12.34M derived: sum of 2 quarters · filed 2018-11-07 | -$22.34M 10-Q · filed 2018-11-07 | -$61.58M derived: sum of 4 quarters · filed 2018-11-07 | ||
| 2017-06-30 | -$8.05M 10-Q · filed 2018-08-03 | -$18.05M 10-Q · filed 2018-08-03 | -$57.29M derived: sum of 3 quarters · filed 2018-08-03 | -$67.49M derived: sum of 4 quarters · filed 2018-08-03 | ||
| 2017-03-31 | -$10.00M 10-Q · filed 2018-05-08 | -$49.24M derived: sum of 2 quarters · filed 2018-05-08 | -$59.44M derived: sum of 3 quarters · filed 2018-05-08 | -$69.64M derived: sum of 4 quarters · filed 2018-05-08 | ||
| 2016-12-31 | -$39.24M 10-K · filed 2017-03-15 | -$49.44M derived: sum of 2 quarters · filed 2017-11-09 | -$59.64M derived: sum of 3 quarters · filed 2017-11-09 | -$39.24M 10-K · filed 2018-02-26 | ||
| 2016-09-30 | -$10.20M 10-Q · filed 2017-11-09 | -$20.40M derived: sum of 2 quarters · filed 2017-11-09 | -$30.66M 10-Q · filed 2017-11-09 | -$58.16M derived: sum of 4 quarters · filed 2017-11-09 | ||
| 2016-06-30 | -$10.20M 10-Q · filed 2017-08-09 | -$10.20M 10-Q · filed 2016-08-04 | -$20.46M 10-Q · filed 2017-08-09 | -$20.47M 10-Q · filed 2016-08-04 | -$47.96M derived: sum of 3 quarters · filed 2017-08-09 | -$50.69M derived: sum of 4 quarters · filed 2017-08-09 |
| 2016-03-31 | -$10.26M 10-Q · filed 2017-05-10 | -$10.27M 10-Q · filed 2016-05-10 | -$37.76M derived: sum of 2 quarters · filed 2017-05-10 | -$40.49M derived: sum of 3 quarters · filed 2017-05-10 | -$50.68M derived: sum of 4 quarters · filed 2017-05-10 | |
| 2015-12-31 | -$27.50M 10-K · filed 2017-03-15 | -$30.23M derived: sum of 2 quarters · filed 2017-03-15 | -$40.42M derived: sum of 3 quarters · filed 2017-03-15 | -$47.60M derived: sum of 4 quarters · filed 2017-03-15 | ||
| 2015-09-30 | -$2.74M 10-Q · filed 2016-11-09 | -$12.92M derived: sum of 2 quarters · filed 2016-11-09 | -$20.09M 10-Q · filed 2016-11-09 | |||
| 2015-06-30 | -$10.19M 10-Q · filed 2016-08-04 | -$17.37M 10-Q · filed 2016-08-04 | ||||
| 2015-03-31 | -$7.18M 10-Q · filed 2016-05-10 | |||||
| 2014-12-31 | -$14.35M 10-K · filed 2017-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |
| LENZ Therapeutics, Inc. (LENZ) | United States | $0.117B | -1.41 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| enGene Therapeutics Inc. (ENGN) | $0.129B | -0.92 | |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B |